Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register

OBJECTIVE: To compare event and incidence rates of herpes zoster (HZ), also known as shingles, in patients with rheumatoid arthritis under treatment with conventional synthetic (cs), targeted synthetic (ts) or biologic (b) disease-modifying antirheumatic drugs (DMARDs). METHODS: Patients were prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Redeker, Imke, Albrecht, Katinka, Kekow, Joern, Burmester, Gerd Rüdiger, Braun, Juergen, Schäfer, Martin, Zink, Angela, Strangfeld, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762036/
https://www.ncbi.nlm.nih.gov/pubmed/34321218
http://dx.doi.org/10.1136/annrheumdis-2021-220651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762036/
https://www.ncbi.nlm.nih.gov/pubmed/34321218
http://dx.doi.org/10.1136/annrheumdis-2021-220651

Ejemplares similares